FDA Gets Aggressive With Companies Over Marketing of Alleged Diabetes Treatments
The U.S. Food and Drug Administration (FDA) has started its campaign to stop sales of multiple products advertised and labeled as diabetes treatments. According to data from 2011, over 25 million people in the U.S. have diabetes and perhaps more alarming is that 79 million people have prediabetes. Clearly there is a market for diabetes remedies.
According to the FDA, companies are taking advantage of consumers seeking diabetes treatments by marketing products that claim to prevent, treat, or relieve symptoms of diabetes, but the FDA has not authorized those claims. The FDA said the products involved might not only be ineffective but could be contaminated and cause people to delay seeking proper medical treatment. Such delay could increase the development of diabetes in those with prediabetes and increase the risk of serious health complications in people with the disease.
The FDA has advised that it will continue to take action against firms that sell illegal diabetes treatment products. Companies in the diabetes remedy market should be aware of the FDA’s recent enforcement actions and revisit their advertising and product labeling to ensure they do not become the FDA’s next target. Links to some of the warning letters can be found here.